Network Pharmacology Analysis of the Mechanisms of Compound Herba Sarcandrae (Fufang Zhongjiefeng) Aerosol in Chronic Pharyngitis Treatment

Yanping Zhang,Taohua Yuan,Yunsong Li,Ning Wu,Xiaotian Dai

DOI: https://doi.org/10.2147/DDDT.S304708

2021-06-28

Abstract:Yanping Zhang, 1, &ast Taohua Yuan, 2, &ast Yunsong Li, 1 Ning Wu, 2 Xiaotian Dai 3 1 Guizhou University of Traditional Chinese Medicine, Guiyang, Guizhou, People's Republic of China; 2 Guizhou Medical University, Guiyang, Guizhou, People's Republic of China; 3 Department of Mathematics and Statistics, University of Calgary, Calgary, Alberta, Canada &astThese authors contributed equally to this work Correspondence: Ning Wu Guizhou Medical University, Guiyang, Guizhou, 550025, People's Republic of China Tel/Fax +86 13765080008 Email Xiaotian Dai Department of Mathematics and Statistics, University of Calgary, Calgary, AB, T2N 1N4, Canada Tel/Fax +1 435 754 4980 Email Purpose: This study aimed to investigate the molecular mechanisms of compound herba Sarcandrae aerosol, also known as the Fufang Zhongjiefeng (FFZJF) aerosol, in treating chronic pharyngitis (CP) using network pharmacology and in vivo experimental approaches. Methods: Active compounds and putative targets of five herbs in FFZJF were identified from the Traditional Chinese Medicine Systems Pharmacology Database and Analysis Platform, Chemistry Database, and Swiss Target Prediction databases. The therapeutic targets of CP were obtained from OMIM, Durgbank, DisGeNT, and GAD databases. The active compounds-target networks were constructed using Cytoscape 3.6.1. The overlapping targets of FFZJF active compounds and CP targets were further analyzed using the String database to construct protein–protein interaction (PPI) network. KEGG pathway and Gene Ontology enrichment analysis was performed using the Database for Annotation, Visualization, and Integrated Discovery. The predicted targets and pathways were validated in a group A β-hemolytic streptococcus-induced rat CP model. Results: There were 45 active compounds identified from FFZJF and 11 potential protein targets identified for CP treatment. PPI network demonstrated that IL6, PTGS2, TLR-4, and TNF may serve as the key targets of FFZJF for the treatment of CP. The main functional pathways involving these key targets include cytokine secretion, inflammatory response, MyD88-dependent toll-like receptor signaling pathway, toll-like receptor signaling pathway, TNF signaling pathway, and NF-κB signaling pathway. In a rat CP model, the elevation of serum TNF-α, IL1β, and IL6 levels, as well as the upregulation of TLR-4, MyD88, NF-κB P65 in the pharyngeal mucosal tissues could be effectively reduced by FFZJF treatment in a dose-dependent manner. Conclusion: Through a network pharmacology approach and animal study, we predicted and validated the active compounds of FFZJF and their potential targets for CP treatment. The results suggest that FFZJF can markedly alleviate GAS-induced chronic pharyngitis by modulating the TLR-4/MyD88/NF-κB signaling pathways. Keywords: chronic pharyngitis, Fufang Zhongjiefeng Aerosol, FFZJF, network pharmacology, TLR-4/MyD88/NF-κB signaling pathway Chronic pharyngitis (CP) is a diffusive inflammation of the pharyngeal mucosa, submucosa, and pharyngeal lymphoid tissues, with a high incidence that accounts for approximately 10–20% of throat diseases. 1 , 2 According to the epidemiological data, at least 20% of the adult population suffers from chronic pharyngitis worldwide. 3 The symptoms of CP are stubborn, and the disease is difficult to cure and causes great inconvenience to the patient. At present, well-known international medical treatments are lozenges, laser and cryotherapy, and antibiotics. However, the disease is likely to break out repeatedly. In recent years, the abuse of many antibiotic drugs leads to the increased the risk of antibiotic resistance and the risk of adverse reactions 4 as well as a significant decrease of the curative effects. Group A β-hemolytic Streptococcus (GAS)-induced pharyngitis is often considered as a trigger of CP, and in 56–97% of CP cases, GAS pharyngitis precedes lesion formation. 5 CP recurs easily, often has a prolonged disease course, and is difficult to treat. 6 The causes of CP can be infectious (bacterial or viral), non-infectious (excessive alcohol use, smoking, voice abuse or misuse), 7 or a recurring acute pharyngitis that is not being treated properly. 7–11 Among the bacterial CP, GAS bacterium is the most common pathogen associated with the disease. 7 , 12 ,<a -Abstract Truncated-